查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1589120

連續血糖監測系統市場：按產品、組件、測試場地、患者照護環境和應用 - 2025-2030 年全球預測

Continuous Blood Glucose Monitoring Systems Market by Product, Component, Testing Site, Patient Care Setting, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

連續血糖監測系統市場2023年估值為45億美元，預計2024年將達到48.6億美元，複合年成長率為8.14%，預計到2030年將達到77.9億美元。

連續血糖監測系統 (CGMS) 是一種動態微創技術，旨在主要為糖尿病患者提供即時血糖濃度評估。對 CGMS 的需求源於全球糖尿病盛行率的不斷上升以及改善血糖控制以減少相關健康併發症的迫切需求。 CGMS 的應用範圍已從糖尿病患者擴展到運動員和其他尋求最佳血糖管理的注重健康的人。最終使用領域包括醫院、診所和家庭護理場所，促進專業和個人健康監測。市場成長是由技術進步、糖尿病管理意識增強以及醫療保健成本上升所推動的。主要影響因素包括人口老化、可支配收入增加以及適應性健康解決方案的納入，尤其是在發展中地區。穿戴式科技創新的最新趨勢提供了巨大的市場機會。追求技術升級和資料整合協作的公司可以有效地利用這些機會。然而，高成本、不同的報銷政策和複雜的監管許可等限制因素正在阻礙成長。新興市場面臨醫療基礎設施和意識有限等挑戰。創新應側重於用戶易用性、準確性的提高以及人工智慧分析的整合以提供預測性見解，以及無線和非侵入性監控方法。特別是感測器的更長壽命和小型化等研究方法可能會導致業務擴張。這個市場充滿活力、競爭激烈，並且在個人化健康監測的迫切需求的推動下，有望實現變革性成長。公司需要專注於研發投資、滿足監管標準以及策略夥伴關係，以充分利用市場潛力。專注於教育宣傳活動、最佳化成本結構和擴大低成本設備的可用性可以進一步緩解當前的障礙並提高市場滲透率。

主要市場統計
基準年[2023] 45億美元
預測年份 [2024] 48.6億美元
預測年份 [2030] 77.9億美元
複合年成長率（%） 8.14%

市場動態：快速發展的連續血糖監測系統市場的關鍵市場洞察

供應和需求的動態交互作用正在改變連續血糖監測系統市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 隨著糖尿病患者數量的增加，需要有效的方法來檢測血糖值的快速變化
    • 連續血糖監測系統與 POC 血糖儀相比的優勢
    • 透過政府主導提高產品知名度
  • 市場限制因素
    • 與測量精度和準確度以及感測器壽命相關的成本
  • 市場機會
    • 家庭醫療保健中連續血糖監測系統的採用率提高
    • 潛在的未確診患者群體
  • 市場挑戰
    • 模式不穩定性和結果的可重複性

波特五力：引領連續血糖監測系統市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解連續血糖監測系統市場的外部影響

外部宏觀環境因素在塑造連續血糖監測系統市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解連續血糖監測系統市場的競爭格局

對連續血糖監測系統市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣連續血糖監測系統市場供應商的績效評估

FPNV 定位矩陣是評估連續血糖監測系統市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了連續血糖監測系統市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對連續血糖監測系統市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 隨著糖尿病患者數量的增加，需要一種有效檢測血糖值快速變化的方法。
      • 與照護現場血糖儀相比，連續血糖監測系統的優勢
      • 透過政府措施提高產品知名度
    • 抑制因素
      • 與測量準確度和精度以及感測器壽命相關的成本
    • 機會
      • 提高連續血糖監測系統在家庭醫療保健中的採用率
      • 潛在的未確診患者群體
    • 任務
      • 模式不穩定性和結果的可重複性
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章連續血糖監測系統市場：依產品

  • 連續血糖監測系統
    • 接收器
    • 感應器
    • 發送器
  • 自我血糖測量系統
    • 血糖值儀
    • 採血針和採血裝置
    • 試紙

第7章連續血糖監測系統市場：依組成部分

  • 動態監測儀
  • 連續監測發射機
  • 葡萄糖感測器

第8章連續血糖監測系統市場（依測試地點）

  • 替代站點測試
  • 指尖測試

第9章按患者照護環境分類的連續血糖監測系統市場

  • 醫院/診所
  • 自我護理或居家護理

第10章連續血糖監測系統市場：依應用分類

  • 妊娠糖尿病
  • 1型糖尿病
  • 2型糖尿病

第11章美洲連續血糖監測系統市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太連續血糖監測系統市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲連續血糖監測系統市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • A. Menarini Diagnostics srl
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Dexcom, Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • GlySens Incorporated
  • Johnson & Johnson Services, Inc.
  • LifeScan IP Holdings, LLC
  • Medtronic PLC
  • Novo Nordisk A/S
  • OrSense Ltd.
  • PHC Holdings Corporation
  • Senseonics Holdings, Inc.
  • Tandem Diabetes Care, Inc.
Product Code: MRR-433AB1DC2935

The Continuous Blood Glucose Monitoring Systems Market was valued at USD 4.50 billion in 2023, expected to reach USD 4.86 billion in 2024, and is projected to grow at a CAGR of 8.14%, to USD 7.79 billion by 2030.

Continuous Blood Glucose Monitoring Systems (CGMS) are dynamic, minimally invasive technologies designed to provide real-time glucose level assessments, primarily for diabetic patients. The necessity for CGMS arises from the growing global diabetes prevalence and the urgent need for better glycemic control to reduce associated health complications. Its applications extend beyond diabetic patients to include athletes and other health-conscious individuals seeking optimal glucose management. End-use sectors include hospitals, clinics, and homecare settings, facilitating both professional and personal health monitoring. Market growth is driven by technological advancements, heightened awareness regarding diabetes management, and rising health expenditures. Key influencing factors include an aging population and increased disposable incomes, particularly in developing regions embedding adaptive health solutions. Recent trends unveiling wearable technology innovations offer significant market opportunities. Companies pursuing collaborations for tech upgrades and data integration can leverage these opportunities effectively. However, limitations such as high costs, varying reimbursement policies, and the complexity of regulatory clearances hinder growth. Emerging markets face challenges like limited healthcare infrastructure and awareness. Innovation should focus on enhancing user ease, accuracy, and integrating AI analytics to offer predictive insights, as well as wireless and non-invasive monitoring methods. Research avenues, particularly in improving sensor longevity and reducing size, will likely lead to business expansion. This market is dynamic, highly competitive, and poised for transformative growth, driven by an urgent demand for personalized health monitoring. Companies need to invest in R&D, align with regulatory standards, and focus on strategic partnerships to harness market potential. Emphasizing education campaigns, optimizing cost structures, and expanding low-cost device availability will further mitigate current barriers and bolster market penetration.

KEY MARKET STATISTICS
Base Year [2023] USD 4.50 billion
Estimated Year [2024] USD 4.86 billion
Forecast Year [2030] USD 7.79 billion
CAGR (%) 8.14%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Continuous Blood Glucose Monitoring Systems Market

The Continuous Blood Glucose Monitoring Systems Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Need an effective way to detect drastic changes in blood glucose for increasing diabetes cases
    • Benefits associated with continuous blood glucose monitoring systems over Point-of-Care glucometers
    • Increasing awareness through government initiatives for the product
  • Market Restraints
    • Accuracy and precision on measurement and cost associated with sensor lifetime
  • Market Opportunities
    • Growing adoption rate of continuous blood glucose monitoring systems in home healthcare
    • Potential undiagnosed patient population
  • Market Challenges
    • Instability of patterns and reproducibility to results

Porter's Five Forces: A Strategic Tool for Navigating the Continuous Blood Glucose Monitoring Systems Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Continuous Blood Glucose Monitoring Systems Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Continuous Blood Glucose Monitoring Systems Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Continuous Blood Glucose Monitoring Systems Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Continuous Blood Glucose Monitoring Systems Market

A detailed market share analysis in the Continuous Blood Glucose Monitoring Systems Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Continuous Blood Glucose Monitoring Systems Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Continuous Blood Glucose Monitoring Systems Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Continuous Blood Glucose Monitoring Systems Market

A strategic analysis of the Continuous Blood Glucose Monitoring Systems Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Continuous Blood Glucose Monitoring Systems Market, highlighting leading vendors and their innovative profiles. These include A. Menarini Diagnostics s.r.l., Abbott Laboratories, B. Braun Melsungen AG, Dexcom, Inc., Eli Lilly and Company, F. Hoffmann-La Roche AG, GlySens Incorporated, Johnson & Johnson Services, Inc., LifeScan IP Holdings, LLC, Medtronic PLC, Novo Nordisk A/S, OrSense Ltd., PHC Holdings Corporation, Senseonics Holdings, Inc., and Tandem Diabetes Care, Inc..

Market Segmentation & Coverage

This research report categorizes the Continuous Blood Glucose Monitoring Systems Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Continuous Glucose Monitoring Systems and Self-Monitoring Blood Glucose Systems. The Continuous Glucose Monitoring Systems is further studied across Receivers, Sensors, and Transmitters. The Self-Monitoring Blood Glucose Systems is further studied across Blood Glucose Meters, Lancets & Lancing Devices, and Testing strips.
  • Based on Component, market is studied across CGM Monitor, CGM Transmitter, and Glucose Sensor.
  • Based on Testing Site, market is studied across Alternate Site Testing and Fingertip Testing.
  • Based on Patient Care Setting, market is studied across Hospital & Clinics and Self or Home Care.
  • Based on Application, market is studied across Gestational Diabetes, Type 1 Diabetes, and Type 2 Diabetes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Need an effective way to detect drastic changes in blood glucose for increasing diabetes cases
      • 5.1.1.2. Benefits associated with continuous blood glucose monitoring systems over Point-of-Care glucometers
      • 5.1.1.3. Increasing awareness through government initiatives for the product
    • 5.1.2. Restraints
      • 5.1.2.1. Accuracy and precision on measurement and cost associated with sensor lifetime
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing adoption rate of continuous blood glucose monitoring systems in home healthcare
      • 5.1.3.2. Potential undiagnosed patient population
    • 5.1.4. Challenges
      • 5.1.4.1. Instability of patterns and reproducibility to results
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Continuous Blood Glucose Monitoring Systems Market, by Product

  • 6.1. Introduction
  • 6.2. Continuous Glucose Monitoring Systems
    • 6.2.1. Receivers
    • 6.2.2. Sensors
    • 6.2.3. Transmitters
  • 6.3. Self-Monitoring Blood Glucose Systems
    • 6.3.1. Blood Glucose Meters
    • 6.3.2. Lancets & Lancing Devices
    • 6.3.3. Testing strips

7. Continuous Blood Glucose Monitoring Systems Market, by Component

  • 7.1. Introduction
  • 7.2. CGM Monitor
  • 7.3. CGM Transmitter
  • 7.4. Glucose Sensor

8. Continuous Blood Glucose Monitoring Systems Market, by Testing Site

  • 8.1. Introduction
  • 8.2. Alternate Site Testing
  • 8.3. Fingertip Testing

9. Continuous Blood Glucose Monitoring Systems Market, by Patient Care Setting

  • 9.1. Introduction
  • 9.2. Hospital & Clinics
  • 9.3. Self or Home Care

10. Continuous Blood Glucose Monitoring Systems Market, by Application

  • 10.1. Introduction
  • 10.2. Gestational Diabetes
  • 10.3. Type 1 Diabetes
  • 10.4. Type 2 Diabetes

11. Americas Continuous Blood Glucose Monitoring Systems Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Continuous Blood Glucose Monitoring Systems Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Continuous Blood Glucose Monitoring Systems Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. A. Menarini Diagnostics s.r.l.
  • 2. Abbott Laboratories
  • 3. B. Braun Melsungen AG
  • 4. Dexcom, Inc.
  • 5. Eli Lilly and Company
  • 6. F. Hoffmann-La Roche AG
  • 7. GlySens Incorporated
  • 8. Johnson & Johnson Services, Inc.
  • 9. LifeScan IP Holdings, LLC
  • 10. Medtronic PLC
  • 11. Novo Nordisk A/S
  • 12. OrSense Ltd.
  • 13. PHC Holdings Corporation
  • 14. Senseonics Holdings, Inc.
  • 15. Tandem Diabetes Care, Inc.

LIST OF FIGURES

  • FIGURE 1. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET RESEARCH PROCESS
  • FIGURE 2. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET DYNAMICS
  • TABLE 7. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY RECEIVERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SENSORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TRANSMITTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY BLOOD GLUCOSE METERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY LANCETS & LANCING DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING STRIPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CGM MONITOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CGM TRANSMITTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY GLUCOSE SENSOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ALTERNATE SITE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY FINGERTIP TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF OR HOME CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY GESTATIONAL DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. INDONESIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. JAPAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. JAPAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 114. JAPAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. MALAYSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. MALAYSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 121. MALAYSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. PHILIPPINES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. PHILIPPINES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 128. PHILIPPINES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SINGAPORE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SINGAPORE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 135. SINGAPORE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. SOUTH KOREA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. SOUTH KOREA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 142. SOUTH KOREA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. TAIWAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. TAIWAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 149. TAIWAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 150. TAIWAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. THAILAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. THAILAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 156. THAILAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 157. THAILAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. VIETNAM CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. VIETNAM CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 163. VIETNAM CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 164. VIETNAM CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 176. DENMARK CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. DENMARK CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 178. DENMARK CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 179. DENMARK CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. EGYPT CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. EGYPT CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 185. EGYPT CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 186. EGYPT CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. FINLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. FINLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 192. FINLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 193. FINLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. FRANCE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. FRANCE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 199. FRANCE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 200. FRANCE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. GERMANY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. GERMANY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 206. GERMANY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 207. GERMANY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 211. ISRAEL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. ISRAEL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 213. ISRAEL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 214. ISRAEL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. ITALY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. ITALY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 220. ITALY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 221. ITALY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. NETHERLANDS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. NETHERLANDS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 227. NETHERLANDS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 228. NETHERLANDS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. NIGERIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. NIGERIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 234. NIGERIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 235. NIGERIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 239. NORWAY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 240. NORWAY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 241. NORWAY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 242. NORWAY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 246. POLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 247. POLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 248. POLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 249. POLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 253. QATAR CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 254. QATAR CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 255. QATAR CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 256. QATAR CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 260. RUSSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 261. RUSSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 262. RUSSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 263. RUSSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY